Bluepharma will open a new manufacturing unit for complex injectable medicines related to gene therapy in Coimbra, which is the result of a mobilising agenda and a growing investment in innovation by the Portuguese pharmaceutical company, according to a business source. The new unit, expected to start operating in April, is the result of a consortium of ten entities, led by the pharmaceutical company based ...